Further, we demonstrate that high expression of PLIN2, the LD coat protein, a marker of lipid phenotype, was observed to be strongly associated with poor overall survival in breast cancer patients, suggesting that PLIN2 could be useful as a biomarker for aggressive breast tumor types and to identify those that may have a greater response to lipid-synthesis inhibition. This evidence concerns the gene PLIN2 and breast carcinoma.